136 related articles for article (PubMed ID: 37718786)
41. Pancreatic neuroendocrine tumors: MR imaging features preoperatively predict lymph node metastasis.
Sun H; Zhou J; Liu K; Shen T; Wang X; Wang X
Abdom Radiol (NY); 2019 Mar; 44(3):1000-1009. PubMed ID: 30539251
[TBL] [Abstract][Full Text] [Related]
42. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades.
Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N
Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681
[TBL] [Abstract][Full Text] [Related]
43. Endoscopic Ultrasound-Guided Therapies in Patients with Pancreatic Neuroendocrine Tumors.
Morgan AD; Ramai D; Bandaru P; Crino SF; Facciorusso A
Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1355-1358. PubMed ID: 37055906
[TBL] [Abstract][Full Text] [Related]
44. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
[TBL] [Abstract][Full Text] [Related]
45. Enhancement patterns in the venous phase of contrast-enhanced ultrasounds: diagnostic value for patients with solid pancreatic lesions.
Chen X; Hao F; Gui Y; Zhang J; Tan L; Xiao M; Zhang Q; Meng H; Li J; Jiang Y; Lv K
Quant Imaging Med Surg; 2021 Oct; 11(10):4321-4333. PubMed ID: 34603987
[TBL] [Abstract][Full Text] [Related]
46. Ultrasound diagnosis of pancreatic solid tumors.
Sofuni A; Tsuchiya T; Itoi T
J Med Ultrason (2001); 2020 Jul; 47(3):359-376. PubMed ID: 31420821
[TBL] [Abstract][Full Text] [Related]
47. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
Makris EA; Cannon JGD; Norton JA; Lopez-Aguiar AG; Dillhoff M; Beal E; Idrees K; Smith PM; Rocha FG; Kanji Z; Cho C; Beems M; Weber S; Fisher A; Krasnick BA; Fields RC; Maithel SK; Poultsides GA
Ann Surg Oncol; 2023 Apr; 30(4):2424-2430. PubMed ID: 36434481
[TBL] [Abstract][Full Text] [Related]
48. Magnetic resonance imaging spectrum of solid pseudopapillary neoplasm of the pancreas.
Chae SH; Lee JM; Baek JH; Shin CI; Yoo MH; Yoon JH; Kim JH; Han JK; Choi BI
J Comput Assist Tomogr; 2014; 38(2):249-57. PubMed ID: 24625600
[TBL] [Abstract][Full Text] [Related]
49. Contrast-enhanced ultrasound of solid pancreatic head lesions: a prospective study.
Gupta P; Rana P; Marodia Y; Samanta J; Sharma V; Sinha SK; Singh H; Gupta V; Yadav TD; Sreenivasan R; Vaiphei K; Rajwanshi A; Kochhar R; Sandhu M
Eur Radiol; 2022 Oct; 32(10):6668-6677. PubMed ID: 35587829
[TBL] [Abstract][Full Text] [Related]
50. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
[TBL] [Abstract][Full Text] [Related]
51. Presentation of Chloromas in B-Mode Ultrasound and Contrast-Enhanced Ultrasound.
Trenker C; Görg C; Burchert A; Michel C; Kipper K; Westhoff CC; Keber CU; Safai Zadeh E
Ultrasound Med Biol; 2022 Sep; 48(9):1933-1940. PubMed ID: 35778304
[TBL] [Abstract][Full Text] [Related]
52. Transabdominal contrast-enhanced ultrasonography of pancreatic cancer.
Kersting S; Roth J; Bunk A
Pancreatology; 2011; 11 Suppl 2():20-7. PubMed ID: 21464583
[TBL] [Abstract][Full Text] [Related]
53. Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2.
Zhao CL; Dabiri B; Hanna I; Lee L; Xiaofei Z; Hossein-Zadeh Z; Cao W; Allendorf J; Rodriguez AP; Weng K; Turunbedu S; Boyd A; Gupta M
Ann Diagn Pathol; 2023 Aug; 65():152149. PubMed ID: 37119647
[TBL] [Abstract][Full Text] [Related]
54. Contrast-enhanced ultrasonography diagnosis of fundal localized type of gallbladder adenomyomatosis.
Tang S; Huang L; Wang Y; Wang Y
BMC Gastroenterol; 2015 Aug; 15():99. PubMed ID: 26239485
[TBL] [Abstract][Full Text] [Related]
55. Application of contrast-enhanced ultrasound in the diagnosis of solid pancreatic lesions--a comparison of conventional ultrasound and contrast-enhanced CT.
Fan Z; Li Y; Yan K; Wu W; Yin S; Yang W; Xing B; Li X; Zhang X
Eur J Radiol; 2013 Sep; 82(9):1385-90. PubMed ID: 23727375
[TBL] [Abstract][Full Text] [Related]
56. Contrast enhanced transabdominal ultrasound in the characterisation of pancreatic lesions with cystic appearance.
Beyer-Enke SA; Hocke M; Ignee A; Braden B; Dietrich CF
JOP; 2010 Sep; 11(5):427-33. PubMed ID: 20818109
[TBL] [Abstract][Full Text] [Related]
57. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
Li JK; Wang M; Yuan J; Song ZG
Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
[No Abstract] [Full Text] [Related]
58. Solid pseudopapillary tumour should be part of differential diagnosis of focal pancreatic lesions with increased
Somme F; Montaz-Rosset MS; Averous G; Deur J; Goichot B; Bachellier P; Addeo P; Imperiale A
Clin Endocrinol (Oxf); 2020 Jul; 93(1):78-81. PubMed ID: 32314437
[TBL] [Abstract][Full Text] [Related]
59. Differential diagnosis of solid pancreatic lesions using contrast-enhanced three-dimensional ultrasonography.
Miwa H; Numata K; Sugimori K; Kaneko T; Sakamaki K; Ueda M; Fukuda H; Tanaka K; Maeda S
Abdom Imaging; 2014 Oct; 39(5):988-99. PubMed ID: 24711063
[TBL] [Abstract][Full Text] [Related]
60. The role of contrast-enhanced ultrasound in the diagnosis of hepatic alveolar echinococcosis.
Cai D; Li Y; Jiang Y; Wang H; Wang X; Song B
Medicine (Baltimore); 2019 Feb; 98(5):e14325. PubMed ID: 30702614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
